ANGEL ONE

(₹20/Trade)

Open Account

MOTILAL OSWAL

Open Account

Stock Market Institue

Trial Class

Book Now

IPOs, NCDs, OFS, Rights Issues, Buyback and Stock Brokers

Mainboard IPOs & FPOS SME IPOs & FPOS NCD Issues Rights Issues IPO Reports Stock Broker Stock Report

Bio Medica Laboratories IPO Details

Bookbuilding IPO | ₹52 Cr | Listing at NSE SME | Thu, May 21, 2026 - Mon, May 25, 2026 CT

Bio Medica Laboratories IPO is a book build issue of ₹52.43 crores. The issue is a combination of fresh issue of 0.34 crore shares aggregating to ₹47.19 crores and offer for sale of 0.04 crore shares aggregating to ₹5.24 crores.

Bio Medica Laboratories IPO opens for subscription on May 21, 2026 and closes on May 25, 2026. The allotment for the Bio Medica Laboratories IPO is expected to be finalized on May 26, 2026. Bio Medica Laboratories IPO will list on the NSE SME with a tentative listing date fixed as May 29, 2026.

Bio Medica Laboratories IPO is set issue price band at ₹132 to ₹139 per share. The lot size for an application is 1,000 shares. The minimum amount of investment required by an individual investor (retail) is ₹2,78,000 (2,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,000 shares), amounting to ₹4,17,000.

Narnolia Financial Services Ltd. is the book running lead manager and Skyline Financial Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Prabhat Financial Services Ltd.

Refer to Bio Medica Laboratories IPO RHP for detailed Information.

IPO Open

Thu, May 21, 2026

IPO Close

Mon, May 25, 2026

Price Band

₹41 per share

Market Cap (Pre-IPO)

₹55.41 Cr

IPO Details

IPO Date

21 to 25 May, 2026
Listing Date

Fri, May 29, 2026T
Face Value

₹10 per share
Price Band

₹132 to ₹139
Lot Size

1.000 Shares
Sale Type

Fresh capital cum OFS
Issue Type

Bookbuilding IPO
Listing At

NSE SME

Total Issue Size

37,72,000 shares (agg. up to ₹52 Cr)
Reserved for Market Maker

1,89,000 shares (agg. up to ₹3 Cr) Prabhat Financial Services Ltd.
Fresh Issue (Ex Market Maker)

32,06,000 shares (agg. up to ₹45 Cr)
Offer for Sale

3,77,000 shares of ₹10 (agg. up to ₹5 Cr)
Net Offered to Public

35,83,000 shares (agg. up to ₹50 Cr)
Share Holding Pre Issue

91,80,001 shares
Share Holding Post Issue

1,25,75,001 shares

IPO Timetable (Tentative)

IPO Open

Thu, May 21, 2026
Allotment

Tue, May 26, 2026
Credit of Shares

Wed, May 27, 2026

IPO Close

Mon, May 25, 2026
Refund

Wed, May 27, 2026
Listing

Fri, May 29, 2026

Issue Reservation

Bio Medica Laboratories IPO comprises a total issue size of 37,72,000 shares. The net offer to the public is 35,83,000 shares, after excluding 1,89,000 shares allotted on a firm basis. Of the Net offer 36,000 (1.00%) are allocated to QIB, 17,55,000 (48.98%) allocated to NII 17,92,000 (50.01%) allocated to RII.

Investor Category	Shares Offered	% of Net Issue	% of Total Issue
QIB Shares Offered	36,000	1.00%	0.95%
NII (HNI) Shares Offered	17,55,000	48.98%	46.53%
− bNII > ₹10L	11,70,000		31.02%
− sNII < ₹10L	5,85,000		15.51%
Retail Shares Offered	17,92,000	50.01%	47.51%
Firm Reservations
Market Maker Shares Offered	1,89,000		5.01%
Total Shares Offered	37,72,000	100.00%	100.00%

IPO Lot Size

Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof.

Application	Lots	Shares	Amount
Individual investors (Retail) (Min)	2	2,000	₹2,78,000
Individual investors (Retail) (Max)	2	2,000	₹2,78,000
S-HNI (Min)	3	3,000	₹4,17,000
S-HNI (Max)	7	7,000	₹9,73,000
B-HNI (Min)	8	8,000	₹11,12,000

IPO Subscription Details

About Bio Medica Laboratories Ltd.

Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.

Product portfolio:

Liquid Injectables: 58 products are offered under this category
Dry powder injectables: 15 products under this category

It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications.

The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh.

It has two manufacturing facilities in Indore, Madhya Pradesh.

Competitive Strengths

Multi-product capability and diversified product portfolio
Experienced promoters, management and employees.
Quality assurance
Established client relationship

Company Financials (Restated)

Period Ended	30 Nov 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	65.17	39.12	19.53	17.57
Total Income	28.63	38.33	15.34	16.25
Profit After Tax	8.66	9.79	2.50	0.33
EBITDA	13.45	15.21	5.63	1.70
NET Worth	17.12	14.73	4.94	2.44
Reserves and Surplus	7.94	5.55	4.84	2.34
Total Borrowing	38.17	15.01	10.49	9.61
Amount in ₹ Crore

IPO Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

# Issue Objects

Est Amt (₹ Cr.)
1 Repayment of loan

6.50
2 Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises

28.50
3 General Corporate Purposes
Total

35.00

Key Performance Indicator (KPI)

KPI	Nov 30, 2025	Mar 31, 2025
ROE	54.41%	99.59%
ROCE	23.22%	48.20%
Debt/Equity	2.23	1.02
RoNW	54.41%	99.59%
PAT Margin	30.35%	25.64%
EBITDA Margin	47.11%	39.83%
Price to Book Value		8.66

Check IPO Peer Comparison here.

	Pre IPO	Post IPO
EPS (₹)	10.67	10.33
P/E (x)	13.03	13.45
Promoter Holding	99.99%
Market Cap	₹174.79 Cr.

Mr. Mukesh Mehta and Mr. Pradeep Mehta are the company promoters.

The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue
The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2025 available in RHP.
The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of November 30, 2025 available in RHP.

IPO Review

[Dilip Davda]

BMLL is engaged in the manufacturing and trading of pharma products in B2B segment. Most of its business comes from contract manufacturing of pharma products. It is operating in a highly competitive and fragmented segment. Based on its recent financial data, the issue appears aggressively priced. Only well-informed/cash surplus/risk seekers may park moderate funds for medium term.

Read detail review…

Bio Medica Laboratories IPO Recommendations

Review By	Subscribe	May Apply	Neutral	Avoid
Brokers	1	0	0	0
Members	0	0	0	0

IPO Subscription Status

The Bio Medica Laboratories IPO is subscribed 2.20 times on May 25, 2026 3:29:59 PM (Day 3). The public issue subscribed 2.82 times in the individual investors category, 15.94 times in the QIB category, and 1.30 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (x)	Shares Offered	Shares bid for	Total Applications
QIB (Ex Anchor)	15.94	36,000	5,74,000	6
NII*	1.30	17,55,000	22,74,000	0
bNII (> ₹10L)	0.86	11,70,000	10,04,000
sNII (< ₹10L)	2.17	5,85,000	12,70,000
Individual Investor	2.82	17,92,000	50,46,000	2,523
Total	2.20	35,83,000	78,94,000	2,982

Total Applications: 2,982

*Market Maker portion is not included to NII/HNI.

IPO Registrar

Skyline Financial Services Pvt.Ltd.

02228511022
ipo@skylinerta.com
Visit Website

IPO Lead Manager(s)

Narnolia Financial Services Ltd. (Past IPO Performance)

Lead Manager Reports

Lead Manager Performance Summary
Lead Manager Performance Tracker

Contact Details

Bio Medica Laboratories Ltd. Address

Plot No. 11B-11C,

Sector-E, Sanwer Road

Industrial Area, Industrial Estate (Indore),

Indore, Madhya Pradesh, 452015

+91 7314102751
companysecretary@biomedica.co.in
Visit Website

IPO FAQs

What is the Bio Medica Laboratories IPO?

Bio Medica Laboratories IPO is a SME IPO of 37,72,000 equity shares of the face value of ₹10 aggregating up to ₹52 Crores. The issue is priced at ₹132 to ₹139. The minimum order quantity is 1000.

The IPO opens on Thu, May 21, 2026, and closes on Mon, May 25, 2026.

Skyline Financial Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.

How to apply in Bio Medica Laboratories IPO through Angel One?

Angel One customers can apply online in Bio Medica Laboratories IPO using UPI as a payment gateway. Angel One customers can apply in Bio Medica Laboratories IPO by login into Angel One Console (back office) and submitting an IPO application form.

Steps to apply in Bio Medica Laboratories IPO through Angel One

Visit the Angel One website and login to Console.
Go to Portfolio and click the IPOs link.
Go to the ‘Bio Medica Laboratories IPO’ row and click the ‘Bid’ button.
Enter your UPI ID, Quantity, and Price.
Submit IPO application form.
Visit the UPI App (net banking or BHIM) to approve the mandate.
Visit Angel One IPO Application Process Review for more detail.

When Bio Medica Laboratories IPO will open?

The Bio Medica Laboratories IPO opens on Thu, May 21, 2026 and closes on Mon, May 25, 2026.

What is the lot size of Bio Medica Laboratories IPO?

Bio Medica Laboratories IPO lot size is 1000, and the minimum amount required for application is ₹2,78,000, with 2 lots being the minimum application size.

How to apply for Bio Medica Laboratories IPO?

You can apply in Bio Medica Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don’t offer banking services. Read more detail about applying IPO online through Angel One , Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

When is Bio Medica Laboratories IPO allotment?

The finalization of Basis of Allotment for Bio Medica Laboratories IPO will be done on Tuesday, May 26, 2026, and the allotted shares will be credited to your demat account by Wed, May 27, 2026. Check the Bio Medica Laboratories IPO allotment status.

When is Bio Medica Laboratories IPO listing date ?

The Bio Medica Laboratories IPO listing date is not yet announced. The tentative date of listing is Fri, May 29, 2026.